Garuda Therapeutics Welcomes Avanish Vellanki as CEO
Cambridge, Massachusetts — Garuda Therapeutics, a pioneering company in blood stem cell therapies, proudly announces the appointment of Avanish Vellanki, M.B.A., as its new President and Chief Executive Officer (CEO), starting immediately. This significant decision comes as Garuda seeks to advance its innovative off-the-shelf stem cell solutions.
A New Chapter for Leadership
Avanish Vellanki succeeds the interim CEO, Dr. Adam Craig, M.D., Ph.D., MBA, who now takes on an independent role within the Board of Directors. The transition to Vellanki's leadership represents a strategic move to enhance the company’s direction and technology.
Insights from the Chairman
Eric Aguiar, M.D., Chairman of the Board, expressed his confidence in Mr. Vellanki’s ability to lead Garuda. "Avanish has a proven track record in building companies with a focus on patient welfare. His leadership will be pivotal as we continue to drive forward our hematopoietic stem cell therapy technology,” he remarked. He also thanked Dr. Craig for his steady guidance during a crucial time for the company.
Vision for the Future
Commenting on his new role, Mr. Vellanki stated, "The quality of our technology platform is unparalleled, and it holds the promise of making stem cell donors unnecessary. This innovative approach to resetting bone marrow function opens up extraordinary possibilities for patients." He highlighted his excitement to join Garuda, especially as it approaches crucial phases of clinical validation for its platform.
Continuing the Journey
Dr. Adam Craig shared his sentiments about stepping down as interim CEO, saying, "It has been a privilege to serve in this capacity. I’m confident that Avanish’s leadership will steer Garuda towards significant developments and innovations." His acknowledgment reflects a stable transition into the company’s future.
Avanish Vellanki's Background
Mr. Vellanki brings two decades of experience in healthcare and investment banking to his role at Garuda. Before joining, he was the cofounder, Chairman, and CEO of Rain Oncology, where he made substantial contributions to advancements in cancer treatments. His career kickstarted on Wall Street at Bear, Stearns & Co., where he focused on small and mid-cap biotechnology companies.
Expertise Across the Industry
Following Bear, Stearns, he transitioned into Global Healthcare Investment Banking at Citigroup, dealing with large-scale biopharmaceutical transactions. Vellanki’s hands-on industry experience includes serving at Proteolix, where he played a role in developing carfilzomib for multiple myeloma patients. His graduate studies included a B.A. from Carleton College and M.B.A. from the Carlson School of Management at the University of Minnesota.
About Garuda Therapeutics
Garuda Therapeutics is on a mission to eliminate the need for stem cell donors in blood stem cell transplants. The company's groundbreaking off-the-shelf hematopoietic stem cell therapies are designed to be HLA compatible, self-renewing, and readily available for patient use. This approach aims to address various blood disorders, offering effective treatment options that could enhance bone marrow function and improve patient outcomes.
Contact Information
For any additional details or inquiries, please reach out to Garuda Therapeutics:
Email: ir@garudatx.com
Frequently Asked Questions
Who is Avanish Vellanki?
Avanish Vellanki is the newly appointed President and CEO of Garuda Therapeutics, taking the reins from interim CEO Dr. Adam Craig.
What is Garuda Therapeutics focused on?
Garuda Therapeutics specializes in off-the-shelf blood stem cell therapies to eliminate the need for stem cell donors.
What background does Avanish Vellanki have?
He has over 20 years of experience in healthcare and investment banking, having worked at Rain Oncology and Citigroup among others.
What technologies is Garuda pursuing?
Garuda's focus is on developing hematopoietic stem cell therapies that are self-renewing and HLA compatible.
How can one contact Garuda Therapeutics?
You can reach them via email at ir@garudatx.com.
